Revance Therapeutics Inc
SWB:RTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revance Therapeutics Inc
SWB:RTI
|
US |
|
Healthcare Integrated Technologies Inc
OTC:HITC
|
US |
|
P
|
Public Power Corporation SA
F:PU8
|
GR |
|
C
|
CSE Global Ltd
SWB:XCC
|
SG |
|
W
|
Wang On Group Ltd
F:WON1
|
HK |
|
I
|
Ivanhoe Mines Ltd
SWB:IYAA
|
CA |
|
A
|
Amrest Holdings SE
XMUN:1QT
|
ES |
|
ExpreS2ion Biotech Holding AB
F:5JD0
|
SE |
|
E
|
Eagle Plains Resources Ltd
XBER:33E
|
CA |
|
E
|
Equipmentshare.Com Inc
NASDAQ:EQPT
|
US |
|
W
|
West African Resources Ltd
F:W25
|
AU |
|
P
|
Public Power Corporation SA
DUS:PU8
|
GR |
|
Medacta Group SA
F:6MD
|
CH |
|
G
|
Genpact Ltd
F:35G
|
BM |
|
A
|
Assicurazioni Generali SpA
XMUN:ASG
|
IT |
|
Alerus Financial Corp
F:5QD
|
US |
|
S
|
Spark New Zealand Ltd
F:NZT
|
NZ |
Bankruptcy Probability
Revance Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Revance Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Revance Therapeutics Inc
NASDAQ:RVNC
|
382.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
318.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Revance Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Revance Therapeutics Inc has total debt of 421m USD. This includes both short-term (0 USD) and long-term (421m USD) debt.
You can find a full breakdown on its Balance Sheet.
